Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites

Letizia Straniero, Valeria Rimoldi, Giulia Soldà, Lucia Mauri, Emanuela Manfredini, Elena Andreucci, Sara Bargiacchi, Silvana Penco, Giovanni P. Gesu, Alessandra Del Longo, Elena Piozzi, Rosanna Asselta, Paola Primignani

Research output: Contribution to journalArticle

Abstract

Oculocutaneous albinism (OCA) is characterized by hypopigmentation of the skin, hair and eye, and by ophthalmologic abnormalities caused by a deficiency in melanin biosynthesis. OCA type IV (OCA4) is one of the four commonly recognized forms of albinism, and is determined by mutation in the SLC45A2 gene. Here, we investigated the genetic basis of OCA4 in an Italian child. The mutational screening of the SLC45A2 gene identified two novel potentially pathogenic splicing mutations: a synonymous transition (c.888G>A) involving the last nucleotide of exon 3 and a single-nucleotide insertion (c.1156+2dupT) within the consensus sequence of the donor splice site of intron 5. As computer-assisted analysis for mutant splice-site prediction was not conclusive, we investigated the effects on pre-mRNA splicing of these two variants by using an in vitro minigene approach. Production of mutant transcripts in HeLa cells demonstrated that both mutations cause the almost complete abolishment of the physiologic donor splice site, with the concomitant unmasking of cryptic donor splice sites. To our knowledge, this work represents the first in-depth molecular characterization of splicing defects in a OCA4 patient.

Original languageEnglish
Pages (from-to)467-471
Number of pages5
JournalJournal of Human Genetics
Volume60
Issue number9
DOIs
Publication statusPublished - Sep 29 2015

Fingerprint

RNA Splice Sites
Mutation
Nucleotides
Oculocutaneous Albinism
Eye Abnormalities
Albinism
Genes
Hypopigmentation
RNA Precursors
Melanins
Consensus Sequence
HeLa Cells
Hair
Introns
Exons
Tissue Donors
Skin
Type IV Oculocutaneous Albinism

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites. / Straniero, Letizia; Rimoldi, Valeria; Soldà, Giulia; Mauri, Lucia; Manfredini, Emanuela; Andreucci, Elena; Bargiacchi, Sara; Penco, Silvana; Gesu, Giovanni P.; Del Longo, Alessandra; Piozzi, Elena; Asselta, Rosanna; Primignani, Paola.

In: Journal of Human Genetics, Vol. 60, No. 9, 29.09.2015, p. 467-471.

Research output: Contribution to journalArticle

Straniero, L, Rimoldi, V, Soldà, G, Mauri, L, Manfredini, E, Andreucci, E, Bargiacchi, S, Penco, S, Gesu, GP, Del Longo, A, Piozzi, E, Asselta, R & Primignani, P 2015, 'Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites', Journal of Human Genetics, vol. 60, no. 9, pp. 467-471. https://doi.org/10.1038/jhg.2015.56
Straniero, Letizia ; Rimoldi, Valeria ; Soldà, Giulia ; Mauri, Lucia ; Manfredini, Emanuela ; Andreucci, Elena ; Bargiacchi, Sara ; Penco, Silvana ; Gesu, Giovanni P. ; Del Longo, Alessandra ; Piozzi, Elena ; Asselta, Rosanna ; Primignani, Paola. / Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites. In: Journal of Human Genetics. 2015 ; Vol. 60, No. 9. pp. 467-471.
@article{dc91cfdb05d14d5c9fe2060847dbb753,
title = "Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites",
abstract = "Oculocutaneous albinism (OCA) is characterized by hypopigmentation of the skin, hair and eye, and by ophthalmologic abnormalities caused by a deficiency in melanin biosynthesis. OCA type IV (OCA4) is one of the four commonly recognized forms of albinism, and is determined by mutation in the SLC45A2 gene. Here, we investigated the genetic basis of OCA4 in an Italian child. The mutational screening of the SLC45A2 gene identified two novel potentially pathogenic splicing mutations: a synonymous transition (c.888G>A) involving the last nucleotide of exon 3 and a single-nucleotide insertion (c.1156+2dupT) within the consensus sequence of the donor splice site of intron 5. As computer-assisted analysis for mutant splice-site prediction was not conclusive, we investigated the effects on pre-mRNA splicing of these two variants by using an in vitro minigene approach. Production of mutant transcripts in HeLa cells demonstrated that both mutations cause the almost complete abolishment of the physiologic donor splice site, with the concomitant unmasking of cryptic donor splice sites. To our knowledge, this work represents the first in-depth molecular characterization of splicing defects in a OCA4 patient.",
author = "Letizia Straniero and Valeria Rimoldi and Giulia Sold{\`a} and Lucia Mauri and Emanuela Manfredini and Elena Andreucci and Sara Bargiacchi and Silvana Penco and Gesu, {Giovanni P.} and {Del Longo}, Alessandra and Elena Piozzi and Rosanna Asselta and Paola Primignani",
year = "2015",
month = "9",
day = "29",
doi = "10.1038/jhg.2015.56",
language = "English",
volume = "60",
pages = "467--471",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites

AU - Straniero, Letizia

AU - Rimoldi, Valeria

AU - Soldà, Giulia

AU - Mauri, Lucia

AU - Manfredini, Emanuela

AU - Andreucci, Elena

AU - Bargiacchi, Sara

AU - Penco, Silvana

AU - Gesu, Giovanni P.

AU - Del Longo, Alessandra

AU - Piozzi, Elena

AU - Asselta, Rosanna

AU - Primignani, Paola

PY - 2015/9/29

Y1 - 2015/9/29

N2 - Oculocutaneous albinism (OCA) is characterized by hypopigmentation of the skin, hair and eye, and by ophthalmologic abnormalities caused by a deficiency in melanin biosynthesis. OCA type IV (OCA4) is one of the four commonly recognized forms of albinism, and is determined by mutation in the SLC45A2 gene. Here, we investigated the genetic basis of OCA4 in an Italian child. The mutational screening of the SLC45A2 gene identified two novel potentially pathogenic splicing mutations: a synonymous transition (c.888G>A) involving the last nucleotide of exon 3 and a single-nucleotide insertion (c.1156+2dupT) within the consensus sequence of the donor splice site of intron 5. As computer-assisted analysis for mutant splice-site prediction was not conclusive, we investigated the effects on pre-mRNA splicing of these two variants by using an in vitro minigene approach. Production of mutant transcripts in HeLa cells demonstrated that both mutations cause the almost complete abolishment of the physiologic donor splice site, with the concomitant unmasking of cryptic donor splice sites. To our knowledge, this work represents the first in-depth molecular characterization of splicing defects in a OCA4 patient.

AB - Oculocutaneous albinism (OCA) is characterized by hypopigmentation of the skin, hair and eye, and by ophthalmologic abnormalities caused by a deficiency in melanin biosynthesis. OCA type IV (OCA4) is one of the four commonly recognized forms of albinism, and is determined by mutation in the SLC45A2 gene. Here, we investigated the genetic basis of OCA4 in an Italian child. The mutational screening of the SLC45A2 gene identified two novel potentially pathogenic splicing mutations: a synonymous transition (c.888G>A) involving the last nucleotide of exon 3 and a single-nucleotide insertion (c.1156+2dupT) within the consensus sequence of the donor splice site of intron 5. As computer-assisted analysis for mutant splice-site prediction was not conclusive, we investigated the effects on pre-mRNA splicing of these two variants by using an in vitro minigene approach. Production of mutant transcripts in HeLa cells demonstrated that both mutations cause the almost complete abolishment of the physiologic donor splice site, with the concomitant unmasking of cryptic donor splice sites. To our knowledge, this work represents the first in-depth molecular characterization of splicing defects in a OCA4 patient.

UR - http://www.scopus.com/inward/record.url?scp=84942793765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942793765&partnerID=8YFLogxK

U2 - 10.1038/jhg.2015.56

DO - 10.1038/jhg.2015.56

M3 - Article

C2 - 26016411

AN - SCOPUS:84942793765

VL - 60

SP - 467

EP - 471

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 9

ER -